I imagine it will take a decent number of patients and data to convince the oncology world that a once a week injectable can treat CCR5+ metastatic cancer, but if and when it does, it will be a home run. The once a week injection and lack of typical cancer side effects is almost unbelievable, but it is proving itself. I’m excited to see what the results from the next 2 patients show.

Also, I believe the basket trial for cancer should be the #1 priority behind the BLA. CYDY needs to get as many people with CCR5+ cancer on this drug as quickly possible.